IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Fredi, Micaela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.107
EU - Europa 1.523
AS - Asia 727
OC - Oceania 8
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 6.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.096
CN - Cina 372
UA - Ucraina 360
DE - Germania 303
IT - Italia 255
HK - Hong Kong 188
FI - Finlandia 145
GB - Regno Unito 118
SG - Singapore 116
IE - Irlanda 104
PL - Polonia 63
FR - Francia 56
RU - Federazione Russa 37
SE - Svezia 32
IN - India 18
BE - Belgio 12
VN - Vietnam 12
CA - Canada 11
AU - Australia 7
MK - Macedonia 7
TR - Turchia 6
CZ - Repubblica Ceca 5
NL - Olanda 5
ES - Italia 4
GR - Grecia 4
SA - Arabia Saudita 4
EU - Europa 3
PK - Pakistan 3
RS - Serbia 3
BR - Brasile 2
CH - Svizzera 2
PH - Filippine 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 6.374
Salva come PNG Salva come JPEG
Città #
Fairfield 717
Woodbridge 481
Ashburn 353
Houston 295
Jacksonville 286
Cambridge 266
Seattle 234
Chandler 219
Wilmington 217
Ann Arbor 213
Hong Kong 188
Princeton 173
Helsinki 122
New York 106
Dublin 104
Beijing 74
Nanjing 69
Singapore 69
Warsaw 63
Brescia 57
Shanghai 42
San Diego 33
Nanchang 31
Des Moines 27
London 24
Shenyang 24
Hebei 22
San Francisco 19
Changsha 18
Munich 17
Jiaxing 16
Los Angeles 16
Milan 14
Tianjin 14
Brussels 12
Cagliari 12
Dong Ket 12
Jinan 11
Dearborn 10
Nürnberg 10
Rozzano 10
Hangzhou 9
Lancaster 9
Ningbo 9
Verona 9
Bergamo 8
Pune 8
Washington 8
Kilburn 7
Rome 7
Ferrara 6
Kunming 6
Orange 6
Ottawa 6
Pordenone 6
Lanzhou 5
Lappeenranta 5
Norwalk 5
Prescot 5
Zhengzhou 5
Bosio 4
Falkenstein 4
Melbourne 4
Strasbourg 4
Turin 4
Boardman 3
Brno 3
Duncan 3
Indiana 3
New Bedfont 3
Novi Sad 3
Redwood City 3
Rho 3
Riyadh 3
Skopje 3
Toronto 3
Acton 2
Amsterdam 2
Atlanta 2
Augusta 2
Changchun 2
Chiswick 2
Clearwater 2
Cosenza 2
Crotone 2
Dallas 2
Frankfurt am Main 2
Fuzhou 2
Genoa 2
Haikou 2
Kocaeli 2
Manerbio 2
Markham 2
Motta Baluffi 2
Palermo 2
Paris 2
Passirano 2
Ponte San Pietro 2
Rawalpindi 2
Santa Cruz de Tenerife 2
Totale 4.930
Salva come PNG Salva come JPEG
Nome #
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 161
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 154
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 135
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 128
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 125
Antiphospholipid antibodies mediate autoimmunity against dying cells. 124
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 124
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 119
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 119
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 118
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 117
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 115
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 114
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 114
The clinico-serological spectrum of overlap myositis 114
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 112
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 112
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 110
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 106
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 106
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 105
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 104
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 103
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 103
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 102
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 102
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 102
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 98
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 97
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 95
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 94
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 90
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 88
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 87
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 86
Myositis autoantibodies and clinical phenotypes 85
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 84
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 82
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 78
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 75
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 73
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 72
Should we treat congenital heart block with fluorinated corticosteroids? 69
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 69
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 68
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 67
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 64
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 61
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 60
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 59
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 59
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 58
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 57
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 57
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 55
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 54
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 53
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 51
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 50
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 48
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 41
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 40
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 39
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 39
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 38
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 34
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 34
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 32
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 31
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 30
Managing puerperium in patients with systemic autoimmune diseases: an update 30
Autoimmune polyglandular syndrome type 4: experience from a single reference center 29
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 28
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 28
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 27
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 27
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 27
Neutrophil Extracellular Traps in the Autoimmunity Context. 24
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 23
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 18
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 17
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 17
Systemic lupus erythematosus: state of the art on clinical practice guidelines 16
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 16
Systemic Vasculitis and Pregnancy 16
Obstetric APS 15
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 15
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 15
Topoisomerase I (SCL 70) Autoantibodies 15
Identifying and managing lupus nephritis during pregnancy 14
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 13
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 13
Typing TREX1 gene in patients with systemic lupus erythematosus 13
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 13
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 12
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 12
What is the best instrument to measure disease activity in SLE? - SLE-DAS vs easy BILAG 11
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 10
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 10
Totale 6.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.535
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.379 0 60 64 192 106 167 150 170 155 176 54 85
2020/20211.343 27 151 66 138 82 189 52 139 120 185 95 99
2021/2022776 67 83 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/202559 23 36 0 0 0 0 0 0 0 0 0 0
Totale 6.571